Literature DB >> 17126601

IL-12p40: an inherently agonistic cytokine.

Andrea M Cooper1, Shabaana A Khader.   

Abstract

IL-12p40 is known as a component of the bioactive cytokines interleukin (IL)-12 and IL-23 but it is not widely recognized as having intrinsic functional activity. Recent publications have altered this perception and support an independent role for IL-12p40. IL-12p40 is induced in excess over the other subunits of IL-12 and IL-23 and can exist in a monomeric or homodimeric form. Its most widely appreciated function is to provide a negative feedback loop by competitively binding to the IL-12 receptor. However, IL-12p40 acts as a chemoattractant for macrophages and promotes the migration of bacterially stimulated dendritic cells. It is associated with several pathogenic inflammatory responses such as silicosis, graft rejection and asthma but it is also protective in a mycobacterial model. An appreciation of the independent function of IL-12p40 is important for improving our understanding of both protective and pathogenic immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126601     DOI: 10.1016/j.it.2006.11.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  134 in total

1.  Characterization of mononuclear phagocytic cells in medaka fish transgenic for a cxcr3a:gfp reporter.

Authors:  Narges Aghaallaei; Baubak Bajoghli; Heinz Schwarz; Michael Schorpp; Thomas Boehm
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Evaluation of the T helper 17 axis in ankylosing spondylitis.

Authors:  Ali Taylan; Ismail Sari; Didem L Kozaci; Arif Yuksel; Safak Bilge; Yasar Yildiz; Gulten Sop; Isil Coker; Necati Gunay; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 3.  Interleukin-12 and tuberculosis: an old story revisited.

Authors:  Andrea M Cooper; Alejandra Solache; Shabaana A Khader
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

4.  Characterization of an IL-12 p40/p35 Truncated Fusion Protein That can Inhibit the Action of IL-12.

Authors:  Denise Skrombolas; Isabel Wylie; Shivana Maharaj; John G Frelinger
Journal:  J Interferon Cytokine Res       Date:  2015-05-04       Impact factor: 2.607

5.  Antigen-activated T cells induce IL-12p75 production from dendritic cells in an IFN-γ-independent manner.

Authors:  K Abdi; N J Singh
Journal:  Scand J Immunol       Date:  2010-12       Impact factor: 3.487

6.  Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter.

Authors:  Marc A Williams; Tirumalai Rangasamy; Stephen M Bauer; Smruti Killedar; Matthew Karp; Thomas W Kensler; Masayuki Yamamoto; Patrick Breysse; Shyam Biswal; Steve N Georas
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

7.  Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems.

Authors:  Paola Zaccone; Oliver T Burton; Sarah Gibbs; Nigel Miller; Frances M Jones; David W Dunne; Anne Cooke
Journal:  J Biomed Biotechnol       Date:  2010-03-01

8.  IL-12 promotes myeloid-derived suppressor cell recruitment and bacterial persistence during Staphylococcus aureus orthopedic implant infection.

Authors:  Cortney E Heim; Debbie Vidlak; Tyler D Scherr; Curtis W Hartman; Kevin L Garvin; Tammy Kielian
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

9.  Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP.

Authors:  Martin McLaughlin; Iraide Alloza; Hung Pham Quoc; Christopher J Scott; Yasuhiko Hirabayashi; Koen Vandenbroeck
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 10.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.